Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nucletron
Veenendaal, Utrecht, Netherlandsnucletron.com ↗
- Ownership
- Private
- Employees
- ~500
- Development stage
- Other
01
Overview
Nucletron is the historical global leader in brachytherapy equipment and software for cancer treatment, offering precise radiotherapy solutions now integrated into Elekta's portfolio; commercial products are used in clinical practice globally, with strong clinical evidence supporting brachytherapy for multiple cancer indications
- Therapeutic areas
- Oncology
- Modalities
- Device
- Industry
- Therapeutic Medical Devices
02
Partnerships
Academic research partners, universities, hospitals (via Brachy Academy)Isodose Control BVElekta
Beyond the preview
Go deeper on Nucletron.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nucletron.